Hansoh Pharmaceutical Group Company Limited (3692.HK)
HKD 18.5
(0.11%)
HKD 18.5
(0.11%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 3.11 Billion | 2.74 Billion | 2.57 Billion | 2.39 Billion | 3.32 Billion | 2.07 Billion |
| Net Income | 3.76 Billion | 2.58 Billion | 2.71 Billion | 2.56 Billion | 2.55 Billion | 2.3 Billion |
| Depreciation & Amortization | 366.38 Million | 344.6 Million | 278.46 Million | 228.23 Million | 189.56 Million | 159.09 Million |
| Deferred income taxes | - | -228.91 Million | 595.62 Million | 698.83 Million | - | - |
| Stock-based compensation | 171.36 Million | 179.41 Million | 65.47 Million | 68.59 Million | - | - |
| Change in working capital | 257.23 Million | 49.5 Million | -661.09 Million | -767.42 Million | 457.57 Million | -43.85 Million |
| Other non-cash items | -740.45 Million | -187.14 Million | -414.3 Million | -406.65 Million | 125.8 Million | -352.33 Million |
| Investing Cash Flow | 1.07 Billion | -5.93 Billion | -2.25 Billion | -2.87 Billion | -7.07 Billion | -1.38 Billion |
| Investments in PPE | -362.52 Million | -272.82 Million | -460.03 Million | -1.42 Billion | -592.47 Million | -407.21 Million |
| Acquisitions | 10.82 Million | -66.64 Million | 1.98 Billion | 1.5 Billion | 6.59 Billion | 671 Thousand |
| Investment purchases | -1.39 Billion | -6.31 Billion | -9.39 Billion | -5.74 Billion | -6.65 Billion | -11.24 Billion |
| Sales/Maturities of investments | 2.26 Billion | 602.14 Million | 7.4 Billion | 4.23 Billion | 61.53 Million | 10.25 Billion |
| Other Investing Activities | 1.29 Billion | 113.26 Million | -1.79 Billion | -1.44 Billion | -6.48 Billion | 8.26 Million |
| Financing Cash Flow | -753.69 Million | -818.14 Million | 3.41 Billion | -1.03 Billion | 7.99 Billion | - |
| Debt repayment | -18.96 Million | -42.48 Million | -12.28 Million | -7.6 Million | -41.66 Million | - |
| Dividends payments | -652.08 Million | -712.18 Million | -380.86 Million | -4.2 Billion | -1.5 Billion | - |
| Common Stock Repurchased | -114.86 Million | -76.61 Million | -57.96 Million | -3.16 Billion | -9.49 Billion | - |
| Common Stock Issuance | -76.87 Million | -63.47 Million | -42.85 Million | 3.17 Billion | 9.53 Billion | - |
| Other Financing Activities | 32.21 Million | 76.61 Million | 3.91 Billion | 3.16 Billion | 9.49 Billion | - |
| Accounts receivables | 341.75 Million | 90.44 Million | -549.34 Million | -881.19 Million | 400.25 Million | -455.25 Million |
| Accounts payables | - | 332.14 Million | -282.25 Million | -464.52 Million | -336.67 Million | 455.25 Million |
| Inventory | -129.53 Million | -40.94 Million | -111.74 Million | 113.77 Million | 57.32 Million | -33.11 Million |
| Other working capital | 90.17 Million | -332.14 Million | 282.25 Million | 464.52 Million | 336.67 Million | -10.74 Million |
| Cash at beginning of period | 2.66 Billion | 6.71 Billion | 3.06 Billion | 5.34 Billion | 964.83 Million | 266.44 Million |
| Cash at end of period | 5.98 Billion | 2.66 Billion | 6.71 Billion | 3.06 Billion | 5.34 Billion | 964.83 Million |
| Capital Expenditure | -362.52 Million | -272.82 Million | -460.03 Million | -1.42 Billion | -592.47 Million | -407.21 Million |
| Effect of forex changes on cash | -122.36 Million | -40.56 Million | -79.28 Million | -762.26 Million | 133.21 Million | 14.9 Million |
| Net cash flow / Change in cash | 3.31 Billion | -4.05 Billion | 3.65 Billion | -2.28 Billion | 4.38 Billion | 698.38 Million |
| Free Cash Flow | 2.75 Billion | 2.46 Billion | 2.11 Billion | 962.83 Million | 2.73 Billion | 1.66 Billion |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2.72 Billion | 1.98 Billion | 3.76 Billion | 1.28 Billion | 2.58 Billion | 1.28 Billion |
| Depreciation & Amortization | 216.76 Million | 181.5 Million | 366.38 Million | 184.87 Million | 344.6 Million | 186.43 Million |
| Deferred income taxes | - | - | - | -183.55 Million | -228.91 Million | 376.22 Million |
| Stock-based compensation | 67.58 Million | 85.14 Million | 171.36 Million | 86.22 Million | 179.41 Million | 128.22 Million |
| Change in working capital | 177.19 Million | 271.41 Million | 257.23 Million | 30.97 Million | 49.5 Million | -599.41 Million |
| Other non-cash items | -504.69 Million | -556.41 Million | -740.45 Million | -444.76 Million | -187.14 Million | -33.65 Million |
| Investing Cash Flow | 2.36 Billion | 32.1 Million | 1.07 Billion | 1.04 Billion | -5.93 Billion | -466.71 Million |
| Investments in PPE | -101.84 Million | -126.96 Million | -362.52 Million | -92.63 Million | -272.82 Million | -86.9 Million |
| Acquisitions | - | - | 10.82 Million | - | -66.64 Million | - |
| Investment purchases | - | - | -1.39 Billion | - | -6.31 Billion | - |
| Sales/Maturities of investments | - | - | 2.26 Billion | - | 602.14 Million | - |
| Other Investing Activities | 2.47 Billion | 159.06 Million | 1.29 Billion | 1.13 Billion | 113.26 Million | -379.8 Million |
| Financing Cash Flow | -4.19 Billion | -703.23 Million | -753.69 Million | -50.45 Million | -818.14 Million | -763.31 Million |
| Debt repayment | -4.19 Billion | - | -18.96 Million | -8.99 Million | -42.48 Million | - |
| Dividends payments | - | -652.08 Million | -652.08 Million | - | -712.18 Million | -712.18 Million |
| Common Stock Repurchased | -33.69 Million | -35.41 Million | -114.86 Million | -79.45 Million | -76.61 Million | -18.55 Million |
| Common Stock Issuance | - | - | -76.87 Million | - | -63.47 Million | - |
| Other Financing Activities | 29.97 Million | -15.74 Million | 32.21 Million | 37.98 Million | 76.61 Million | -32.57 Million |
| Accounts receivables | 268.89 Million | 96.21 Million | 341.75 Million | 245.54 Million | 90.44 Million | -550.81 Million |
| Accounts payables | - | - | - | - | 332.14 Million | - |
| Inventory | -30.48 Million | 18.67 Million | -129.53 Million | -148.21 Million | -40.94 Million | 46.36 Million |
| Other working capital | -61.21 Million | 156.52 Million | 90.17 Million | -66.35 Million | -332.14 Million | -94.96 Million |
| Cash at beginning of period | 5.98 Billion | 4.73 Billion | 2.66 Billion | 2.66 Billion | 6.71 Billion | 2.7 Billion |
| Cash at end of period | 6.79 Billion | 4.73 Billion | 5.98 Billion | 4.73 Billion | 2.66 Billion | 2.66 Billion |
| Capital Expenditure | -101.84 Million | -126.96 Million | -362.52 Million | -92.63 Million | -272.82 Million | -86.9 Million |
| Effect of forex changes on cash | -39.23 Million | -49.98 Million | -122.36 Million | -72.37 Million | -40.56 Million | 221.27 Million |
| Net cash flow / Change in cash | 815.69 Million | - | 3.31 Billion | 2.06 Billion | -4.05 Billion | -41.39 Million |
| Free Cash Flow | 2.58 Billion | 1.84 Billion | 2.75 Billion | 1.05 Billion | 2.46 Billion | 880.45 Million |
ACONW
WAL-PA
4664
AMC
CPS
002009